Structure-based modelling in reproductive toxicology: (Q)SARs for the placental barrier

The replacement of animal testing for endpoints such as reproductive toxicity is a long-term goal. This study describes the possibilities of using simple (quantitative) structure-activity relationships ((Q)SARs) to predict whether a molecule may cross the placental membrane. The concept is straightforward, if a molecule is not able to cross the placental barrier, then it will not be a reproductive toxicant. Such a model could be placed at the start of any integrated testing strategy. To develop these models the literature was reviewed to obtain data relating to the transfer of molecules across the placenta. A reasonable number of data were obtained and are suitable for the modelling of the ability of a molecule to cross the placenta. Clearance or transfer indices data were sought due to their ability to eliminate inter-placental variation by standardising drug clearance to the reference compound antipyrine. Modelling of the permeability data indicates that (Q)SARs with reasonable statistical fit can be developed for the ability of molecules to cross the placental barrier membrane. Analysis of the models indicates that molecular size, hydrophobicity and hydrogen-bonding ability are molecular properties that may govern the ability of a molecule to cross the placental barrier. †Presented at the 12th International Workshop on Quantitative Structure-Activity Relationships in Environmental Toxicology (QSAR2006), 8–12 May 2006, Lyon, France.

[1]  D. Morgan,et al.  Transfer of acipimox across the isolated perfused human placenta. , 1991, Placenta.

[2]  P. Myllynen,et al.  Transplacental passage of lamotrigine in a human placental perfusion system in vitro and in maternal and cord blood in vivo , 2003, European Journal of Clinical Pharmacology.

[3]  B. Casey,et al.  Ex vivo human placental transfer of trovafloxacin. , 2000, Infectious diseases in obstetrics and gynecology.

[4]  Roger L. Nation,et al.  Differential Bidirectional Transfer of Indinavir in the Isolated Perfused Human Placenta , 2005, Antimicrobial Agents and Chemotherapy.

[5]  M. Eadie,et al.  Transplacental transfer and biotransformation studies of valproic acid and its glucuronide(s) in the perfused human placenta. , 1989, The Journal of pharmacology and experimental therapeutics.

[6]  O Pelkonen,et al.  Transfer of clonidine and dexmedetomidine across the isolated perfused human placenta , 1997, Acta anaesthesiologica Scandinavica.

[7]  T. Strowitzki,et al.  Glucose transporter proteins (GLUT) in human endometrium: expression, regulation, and function throughout the menstrual cycle and in early pregnancy. , 2003, The Journal of clinical endocrinology and metabolism.

[8]  G. Duan,et al.  Simultaneous determination of ropivacaine and antipyrine by high performance liquid chromatography and its application to the in vitro transplacental study. , 2004, Biomedical chromatography : BMC.

[9]  M. Garland.  Pharmacology of drug transfer across the placenta. , 1998, Obstetrics and gynecology clinics of North America.

[10]  K. Vähäkangas,et al.  Transfer of lidocaine and bupivacaine across the isolated perfused human placenta. , 1995, Pharmacology & toxicology.

[11]  A. Malek.  Ex vivo human placenta models: transport of immunoglobulin G and its subclasses. , 2003, Vaccine.

[12]  D. Feig,et al.  Maternal-Fetal Transport of Hypoglycaemic Drugs , 2003, Clinical pharmacokinetics.

[13]  A. Kilicyazgan,et al.  Endocrine , 1993, Emergencies in Clinical Medicine.

[14]  T S King,et al.  The transfer of cocaine and its metabolites across the term human placenta , 1993, Clinical pharmacology and therapeutics.

[15]  D. Mock,et al.  Human placental biotin transport: normal characteristics and effect of ethanol. , 1993, Alcoholism, clinical and experimental research.

[16]  Mark T. D. Cronin,et al.  Predicting Chemical Toxicity and Fate , 2004 .

[17]  M. Zakowski,et al.  Transfer and uptake of alfentanil in the human placenta during in vitro perfusion. , 1994, Anesthesia and analgesia.

[18]  B. Bannwarth,et al.  Placental transfer of SR49059 in the human dually perfused cotyledon in vitro. , 2001, Placenta.

[19]  P. Myllynen,et al.  Human placenta: a human organ for developmental toxicology research and biomonitoring. , 2005, Placenta.

[20]  M. Cichna,et al.  Placental passage of clarithromycin surpasses other macrolide antibiotics. , 2003, American journal of obstetrics and gynecology.

[21]  P. Hohlfeld,et al.  Placental Transfer of Pyrimethamine Studied in an ex vivo Placental Perfusion Model , 2000, Neonatology.

[22]  R. Johnson,et al.  Transfer of methohexital across the perfused human placenta. , 2000, Journal of clinical anesthesia.

[23]  G. Mathern,et al.  Epilepsia , 1991, NEURO FUNDAMENTAL.

[24]  M. Zakowski,et al.  Sufentanil transfer in the human placenta during in vitro perfusion , 1997, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[25]  J. Dancis,et al.  Transfer of 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 across the perfused human placenta. , 1984, American journal of obstetrics and gynecology.

[26]  H. Fernandez,et al.  Models for Placental Transfer Studies of Drugs , 1995, Clinical pharmacokinetics.

[27]  H. Schneider,et al.  Transfer and Metabolism of Carnitine and Carnitine Esters in the in Vitro Perfused Human Placenta , 1985, Pediatric Research.

[28]  G. Hankins,et al.  Bidirectional transfer of methadone across human placenta. , 2005, Biochemical pharmacology.

[29]  Kirsi Vähäkangas,et al.  Ex vivo perfusion of the human placental cotyledon: implications for anesthetic pharmacology , 2000 .

[30]  M. V. St-Pierre,et al.  Mechanisms of drug transfer across the human placenta-a workshop report. , 2002, Placenta.

[31]  T. Nanovskaya,et al.  Transfer of l-α-Acetylmethadol (LAAM) and l-α-Acetyl-N-normethadol (norLAAM) by the Perfused Human Placental Lobule , 2003, Journal of Pharmacology and Experimental Therapeutics.

[32]  G. Koren.  Glyburide and fetal safety; transplacental pharmacokinetic considerations. , 2001, Reproductive toxicology.

[33]  A. Trounson,et al.  Early human development. , 1999, Human reproduction update.

[34]  G. Pacifici.  Transfer of antivirals across the human placenta. , 2005, Early human development.

[35]  V. Ganapathy,et al.  Placental transporters relevant to drug distribution across the maternal-fetal interface. , 2000, The Journal of pharmacology and experimental therapeutics.

[36]  J. Dancis,et al.  Transfer of zidovudine (AZT) by human placenta. , 1990, The Journal of infectious diseases.

[37]  K. Audus,et al.  Controlling drug delivery across the placenta. , 1999, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[38]  C. Roberts,et al.  Growth and function of the normal human placenta. , 2004, Thrombosis research.

[39]  Alfred N. Martin.  Physical Pharmacy: Physical Chemical Principles in the Pharmaceutical Sciences , 1969 .

[40]  A. Papas,et al.  Antioxidant transport by the human placenta. , 1998, Clinical nutrition.

[41]  D. Wimberly,et al.  The maternal-fetal transfer of bisheteroypiperazine (U-87201-E) in the ex vivo human placenta. , 1995, American journal of obstetrics and gynecology.

[42]  G. Koren,et al.  The transfer, of cocaethylene across the human term placental cotyledon perfused in vitro. , 1997, Reproductive toxicology.

[43]  S. Schenker,et al.  Human placental transport of cimetidine. , 1987, The Journal of clinical investigation.

[44]  T. Nanovskaya,et al.  Transplacental transfer and metabolism of buprenorphine. , 2002, The Journal of pharmacology and experimental therapeutics.

[45]  R. Bawdon,et al.  Placental transfer of ritonavir with zidovudine in the ex vivo placental perfusion model. , 1998, American journal of obstetrics and gynecology.

[46]  L. Mandelbrot,et al.  Maternal-fetal transfer of saquinavir studied in the ex vivo placental perfusion model. , 2001, American journal of obstetrics and gynecology.

[47]  H. Schneider,et al.  Transplacental transfer of beta-adrenergic drugs studied by an in vitro perfusion method of an isolated human placental lobule. , 1983, American journal of obstetrics and gynecology.

[48]  O. Pelkonen,et al.  Antepartum glucocorticoid therapy suppresses human placental xenobiotic and steroid metabolizing enzymes. , 2000, Placenta.

[49]  Miss A.O. Penney.  (b) , 1974, The New Yale Book of Quotations.

[50]  Pasanen,et al.  The expression and regulation of drug metabolism in human placenta. , 1999, Advanced drug delivery reviews.

[51]  S. Deborde,et al.  Placental glucose transfer and fetal growth , 2002, Endocrine.

[52]  O Pelkonen,et al.  Carbamazepine and Its Metabolites in Human Perfused Placenta and in Maternal and Cord Blood , 1995, Epilepsia.

[53]  M. Panigel.  Placental perfusion experiments , 1962 .

[54]  G. Koren,et al.  Transfer of morphine across the human placenta and its interaction with naloxone. , 1999, Life sciences.

[55]  S. Schenker,et al.  A comparative evaluation of the transport of H2-receptor antagonists by the human and baboon placenta. , 1988, The American journal of the medical sciences.

[56]  W. Rosner,et al.  Effect of protein binding on transfer and metabolism of cortisol in perfused human placenta. , 1978, The Journal of clinical endocrinology and metabolism.

[57]  C. Tashiro,et al.  Effects of protein binding on the placental transfer of propofol in the human dually perfused cotyledon in vitro. , 2000, British journal of anaesthesia.

[58]  M. Bassily,et al.  Determinants of placental drug transfer: studies in the isolated perfused human placenta. , 1995, Journal of pharmaceutical sciences.

[59]  H. V. Johnson,et al.  Transfer of lidocaine across the dual perfused human placental cotyledon. , 1999, International journal of obstetric anesthesia.

[60]  T. Ala-Kokko,et al.  Placental transfer of sulindac, sulindac sulfide, and indomethacin in a human placental perfusion model. , 1999, American journal of obstetrics and gynecology.

[61]  M. Katz,et al.  Transfer of ciprofloxacin, ofloxacin and levofloxacin across the perfused human placenta in vitro. , 2005, European journal of obstetrics, gynecology, and reproductive biology.

[62]  L. Gilstrap,et al.  The transfer of the nucleoside analog ganciclovir across the perfused human placenta. , 1994, American journal of obstetrics and gynecology.

[63]  J. Downing,et al.  Bupivacaine Transfer across the Human Term Placenta: A Study Using the Dual Perfused Human Placental Model , 1995, Anesthesiology.

[64]  H. V. Johnson,et al.  Effects of Fetal pH on Local Anesthetic Transfer across the Human Placenta , 1996, Anesthesiology.

[65]  J. Dancis,et al.  Transfer across the perfused human placenta of antipyrine, sodium and leucine. , 1972, American journal of obstetrics and gynecology.

[66]  S. Kaul,et al.  The ex vivo transfer of the anti-HIV nucleoside compound d4T in the human placenta. , 1994, Gynecologic and obstetric investigation.

[67]  V. Ganapathy,et al.  Role of transporters in placental transfer of drugs. , 2005, Toxicology and applied pharmacology.

[68]  M. S. Ching,et al.  Mechanism of triamterene transfer across the human placenta. , 1988, The Journal of pharmacology and experimental therapeutics.

[69]  F. Mondon,et al.  Placental transport of hexoses: a comparative study with antipyrine and amino acids. , 1985, Placenta.

[70]  Gian Maria Pacifici,et al.  Placental Transfer of Drugs Administered to the Mother , 1995, Clinical pharmacokinetics.

[71]  O. Langer,et al.  Comparative placental transport of oral hypoglycemic agents in humans: a model of human placental drug transfer. , 1994, American journal of obstetrics and gynecology.

[72]  J. Dancis,et al.  Lack of effect of cocaine on lysine and alanine uptake in human placental villi or transfer in perfused human placenta. , 1995, Reproduction, fertility, and development.

[73]  R. Sager,et al.  Asymmetrical transport of glucose across the in vitro perfused human placenta. , 2003, Placenta.

[74]  Sastry.  Techniques to study human placental transport. , 1999, Advanced drug delivery reviews.

[75]  J. Dancis,et al.  Transfer of Riboflavin by the Perfused Human Placenta , 1985, Pediatric Research.

[76]  Jashvant D Unadkat,et al.  Placental drug transporters. , 2004, Current drug metabolism.

[77]  B. Little,et al.  Placental transfer of selected substances of abuse. , 1996, Seminars in perinatology.

[78]  M. Huleihel,et al.  Lack of interaction of digoxin and P-glycoprotein inhibitors, quinidine and verapamil in human placenta in vitro. , 2003, European journal of obstetrics, gynecology, and reproductive biology.

[79]  M. Pasanen,et al.  Maternal drug abuse and human term placental xenobiotic and steroid metabolizing enzymes in vitro. , 2000, Environmental health perspectives.

[80]  K. Audus,et al.  Efflux transporters of the human placenta. , 2003, Advanced drug delivery reviews.

[81]  L. Gilstrap,et al.  The maternal-fetal transfer of lamivudine in the ex vivo human placenta. , 1996, American journal of obstetrics and gynecology.

[82]  R. Bawdon,et al.  The transfer of anti-human immunodeficiency virus nucleoside compounds by the term human placenta , 1992 .

[83]  Judith C Madden,et al.  Structure-based methods for the prediction of drug metabolism , 2006, Expert opinion on drug metabolism & toxicology.

[84]  R. Bawdon,et al.  Transfer of Ceftizoxime Surpasses That of Cefoperazone by the Isolated Human Placenta Perfused In Vitro , 1990, Obstetrics and gynecology.

[85]  A. Worth,et al.  The prospects for using (Q)SARs in a changing political environment--high expectations and a key role for the european commission's joint research centre , 2004, SAR and QSAR in environmental research.

[86]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[87]  G. Koren,et al.  Transplacental transfer and biotransformation studies of nicotine in the human placental cotyledon perfused in vitro. , 1998, Life sciences.

[88]  Sabcho D Dimitrov,et al.  A systematic approach to simulating metabolism in computational toxicology. I. The TIMES heuristic modelling framework. , 2004, Current pharmaceutical design.

[89]  S. Schenker,et al.  Transfer of dideoxyinosine across the human isolated placenta. , 1994, British journal of clinical pharmacology.

[90]  J. Challier,et al.  Clearance of compounds of different molecular size in the human placenta in vitro. , 1985, Biology of the neonate.